PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.45%
Positive revenue growth while MCHP is negative. John Neff might see a notable competitive edge here.
11.88%
Gross profit growth at 75-90% of MCHP's 13.31%. Bill Ackman would demand operational improvements to match competitor gains.
20.05%
EBIT growth below 50% of MCHP's 96.56%. Michael Burry would suspect deeper competitive or cost structure issues.
20.81%
Operating income growth under 50% of MCHP's 88.14%. Michael Burry would be concerned about deeper cost or sales issues.
21.69%
Net income growth under 50% of MCHP's 215.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
22.86%
EPS growth under 50% of MCHP's 212.50%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
22.33%
Diluted EPS growth under 50% of MCHP's 228.57%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.60%
Share reduction while MCHP is at 0.32%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.69%
Reduced diluted shares while MCHP is at 0.63%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth under 50% of MCHP's 0.11%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
87.79%
OCF growth above 1.5x MCHP's 30.92%. David Dodd would confirm a clear edge in underlying cash generation.
100.52%
FCF growth above 1.5x MCHP's 34.88%. David Dodd would verify if the firm’s strategic investments yield superior returns.
61.16%
10Y revenue/share CAGR under 50% of MCHP's 231.64%. Michael Burry would suspect a lasting competitive disadvantage.
38.87%
5Y revenue/share CAGR under 50% of MCHP's 124.68%. Michael Burry would suspect a significant competitive gap or product weakness.
26.13%
3Y revenue/share CAGR under 50% of MCHP's 59.01%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
61.31%
10Y OCF/share CAGR under 50% of MCHP's 170.92%. Michael Burry would worry about a persistent underperformance in cash creation.
63.85%
Below 50% of MCHP's 360.78%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
33.59%
3Y OCF/share CAGR under 50% of MCHP's 80.26%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
137.49%
Net income/share CAGR above 1.5x MCHP's 46.78% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
87.46%
5Y net income/share CAGR above 1.5x MCHP's 22.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
66.91%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
41.50%
10Y equity/share CAGR 1.25-1.5x MCHP's 35.54%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
10.21%
5Y equity/share CAGR at 50-75% of MCHP's 17.20%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
12.58%
3Y equity/share CAGR similar to MCHP's 13.72%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
522.75%
10Y dividend/share CAGR above 1.5x MCHP's 44.18%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
191.83%
5Y dividend/share CAGR above 1.5x MCHP's 3.44%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.48%
3Y dividend/share CAGR above 1.5x MCHP's 1.59%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
7.28%
AR growth well above MCHP's 5.33%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.99%
Asset growth above 1.5x MCHP's 0.99%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.24%
BV/share growth above 1.5x MCHP's 1.56%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.07%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.